trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['lung', 'destiny,lung01', 'astrazeneca']
top story: drugs &amp; pharma cos news : 'tomorrow at #esmo22, we ll be sharing updated results from the destiny-lung01 phase ii trial in patients with non-small cell lung cancer whose tumors have an abnormal see more 
Born in Italy, 1969.